{"name":"BMI Korea","slug":"bmi-korea","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BMI2006","genericName":"BMI2006","slug":"bmi2006","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"BMI2006","genericName":"BMI2006","slug":"bmi2006","phase":"phase_3","mechanism":"BMI2006 is a small molecule drug that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE8yYjRzV0J3N2gzTldKY1dtVkw2R21PbWpaenFOMkstSmdEOHZpdXRkRDdYbkFpYlZRUktWRDFrV1kyYml4cHhrdUZ6RFNBTkRFQWRxNmNlSnFGeV9SWjNReTVZZDRHUGxuSmNPZEhR0gFyQVVfeXFMUFRaaWxZelVHSXphbTFJeVRhWGZmZnY4eXZIMHB5RFRPOVFUdTZySXctUVdUb0lseGhrMV93TkVfcnVOUm14MDZjUV9idUljTEUzUkNaaXRtOVdCTmJXWXFTbUEyd2xJYVc1NkptUDcyZlRB?oc=5","date":"2026-03-03","type":"trial","source":"koreabiomed.com","summary":"Wegovy improves muscle quality despite weight loss: SNUBH data - koreabiomed.com","headline":"Wegovy improves muscle quality despite weight loss: SNUBH data","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNb29QalhyT2dWTE9odWV5VjM2WUtJdlBBb3lWWXByRG94X1BVVVNON3hRMmdwbWZxU09PQm8tM01jUWZwbUpwemhuTUJYR1BBbU9oT2d6SDh3em91OGtGVDBuVF9RaVVJRC1fR0JTUThTa0txTGNOdlpzbDZBVzFqUXhFdXBMV0hzdjJGYmtVdThlQmVwV1HSAZsBQVVfeXFMT2VFTVBJdm54QTRQaWdjQ2I4S1QzckFrS3ZJa2xTVGxUUlkwaXFLMlBIcVFpQzVQRWdqM1JHRF85RkFaQ1lCSUhZeVlPYXNObHRfRUh6N2gzRWhLU2dYS1FhMFFKQUI0b3l5cG1jMlNIVUtDNmF6d19RTkptelhGZHJPSmFpM0ZJTUZCZktDMWx5cDR5WENqMjVGUTg?oc=5","date":"2026-02-17","type":"patent","source":"Inquirer.net","summary":"Generic meds seen taking 54% of Philippine pharma sales by 2030 - Inquirer.net","headline":"Generic meds seen taking 54% of Philippine pharma sales by 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNVVc4Z1lxX01NNmpmZFV4bzVobWFFOHlUbDhXZEdyR1JNaVp3NjE2b3oxTEJoeEphNVhxMk8weWQwYU5fa3JTMzZYMS15SkVUREZZR3NoUk9GVll6b2tLaVJSSDBiTXkycnhha1gzNm5LZkRBZkgyZVU0SWhNeWZudlNlbVhoRFUzMmpZOHlDTFd0WTgwLUs0?oc=5","date":"2025-12-01","type":"pipeline","source":"Market Growth Reports","summary":"Polydeoxyribonudeotide (PDRN) Market Overview - Market Growth Reports","headline":"Polydeoxyribonudeotide (PDRN) Market Overview","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFBZdGxuRUlOVmlIcHZiVHhRbU9BRDZpUTFMRzl6c3E3SXRRbUFRZ3phb0tOc29XUU12V0p2MldaZ1ZtcXpIOXlZb2V2YU03LVdVM3p2VnJ6SklqQ08zQ0ZZTG5mcUJYUjBiWHVEQmJoakNYYkRBd2VjakIyNXZIQQ?oc=5","date":"2025-11-26","type":"pipeline","source":"Statista","summary":"Distribution of BMI in South Korea 2023 - Statista","headline":"Distribution of BMI in South Korea 2023","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxOZXp6a0tpdGhwa21hbHVrSVRXWVRBd1VMZTlJNDhWRlF6b0prLUIxNDRoU3BfNHgtSnNxbHlMOF9zRnprSmZSVHl3VE1NTFNuNHMyLVJTbHdqdS1NSE05NjVJdjlncGRhZVJLY2o4SFNVMHpLdEV5T2FieVJlUUo5R2x3bw?oc=5","date":"2025-11-26","type":"pipeline","source":"Statista","summary":"Average BMI of women in their 20s South Korea 2001-2023 - Statista","headline":"Average BMI of women in their 20s South Korea 2001-2023","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5yWi1takdFcHloMjBGbW5rMUNLS0lJMzdvVTA3SDdGQ0dJbzJhZjFuQzFVVW4tYW5XMWhYTUNGdUpiT1FmRWgxNjljbmVRU2VQUTJMWlJ1QmxMU2NGTnNPaW9QTGswcmN1ejFKTUlR0gFyQVVfeXFMUEFHU1hCMXVGQ004UWZqUWVfVVd2bjZJaWtTVHZxbHJXT0ZaRUQyNXBXTEMxS0RuT1JhZjF5dWxDU21tOWRtajdEV3hkME1nbTJrYWp1WkRxRUFpWlBoczBIZ3phcnNmMUs2aUxBNjBxNThn?oc=5","date":"2025-10-29","type":"pipeline","source":"koreabiomed.com","summary":"After Korea’s nod of Wegovy for teens, Novo makes a push for insured, supervised care - koreabiomed.com","headline":"After Korea’s nod of Wegovy for teens, Novo makes a push for insured, supervised care","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5DZVkxU0dtZzZSNGJ6bzFTa0tYOEJLRXg3VlprekZCNW9XcnAwT0swczNvOGxieVptdkVrd0VCUXZlZ1F5QWRMS2NfcjdySVpmZWx1WFh1R21NVzlOZWhzVFQ4SER6bG1UUlZQTVZn0gFyQVVfeXFMUFl4Ym5PTkI1R3JsMGE5MDFzM2pEb1ZQUXA3M1VncklGcFhyTVhqZE11czVRMU1NRWV4djZreV8zOU9TUVpwUEptbU9TMjRYRmMxLXhoaWlCd1Y5alAxYU5fbjJXbW9PcFJDai1aS3ZZN0lR?oc=5","date":"2025-10-24","type":"regulatory","source":"koreabiomed.com","summary":"Novo’s Wegovy scores Korean approval for adolescent obesity care - koreabiomed.com","headline":"Novo’s Wegovy scores Korean approval for adolescent obesity care","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBhaGNEQzNRMTdrNGpmdjBiNXJaQ2U5Z0VCZDlXTmFrcW9EaDMyTWxYb1YyVGxzNmpHQzZsZUVfY3YydUFiZW5YY1ZsS2RKZWF6My1IRFVsQVdETWxJd3NTNmNXY1VQWldwSXNtX3Bn0gFyQVVfeXFMUEFHczV6SzBhaUE3SU5DWjVpOVJ5aHI4Y1Z3T1RJUFBaNjdNVUw4ZEROOGlFRjZreTZHbTZIcVNXT3VLdDBzU1VmRDJZTXFuNVhKcC1OMVlUVWdHbVFySHBjNEtMR2tlVjBIS2xhd0xVQ25B?oc=5","date":"2025-10-23","type":"pipeline","source":"koreabiomed.com","summary":"Wegovy ushers in double-digit weight loss era, redefining metabolic disease treatment - koreabiomed.com","headline":"Wegovy ushers in double-digit weight loss era, redefining metabolic disease treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5zSGFzX09qTXRBX29EdkNRdDFQSzBJLTBCOXp1TFNZdVFWcnlwZ1NIVDV2OWVzMGwxVFdFNmJfWW14N21TbjF6RjlxQTJuN1Y5eTFkVUdodmpQUUpNUm4xbEZNajV3eUp3MGlDVUNR0gFyQVVfeXFMTjJ6eGlvemp1V1FLZVg2ZnMxOTZaNURkZFZwM0ljYmNwLVNYUTJkMnMzZU9FZkNrcHVrS0xJWVJqaU56OWJvUGhiWUh1VW9CcUtnZDBkLUk0MERJUmpPNkFaYUZmM0ZpS1VPc3ptWFhNSkR3?oc=5","date":"2025-07-18","type":"pipeline","source":"koreabiomed.com","summary":"Lilly’s Forteo faces new challenger as PharmaResearch wins biosim nod in Korea - koreabiomed.com","headline":"Lilly’s Forteo faces new challenger as PharmaResearch wins biosim nod in Korea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxOY1NlU0pCZXJLRWFtTUFsMERacGlURnlodXk5SjRzTGFQM2ZPbHF1Z3JNYkF0akRqWGk2REhoY0lNUGxzMGIxc0JHRVRNZERxY3p1czhPdGFDdl9oWlpyV2VET2w0bFVoa1FDd2I4a3RobEE3Q3FJVTlLVmFYLXl5dkpkM1hzYTBrZi1vcUhham1PLVBlbnZfU3lTdHFXOWE4YmtXOXlTRnNDTWxpMVJ1cllBeDBpR0pwd1FSYmRfRjNqbTJ6aWFuVERzTHlsdFNVRWs4UQ?oc=5","date":"2025-02-20","type":"deal","source":"BioPharma APAC","summary":"South Korea’s Brexogen Out-Licenses BxC-I17e to BMI Korea in Landmark Exosome Therapeutics Deal - BioPharma APAC","headline":"South Korea’s Brexogen Out-Licenses BxC-I17e to BMI Korea in Landmark Exosome Therapeutics Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOd01idU8wbndkbnlSTTJtMTBtaTVwbnl4dERDQnZYOFV6cmRHMWQ1Y2ZRelVnRlpyOG1UbUJIbm9RSl9GbWJITS1fVjBtcGw0Q194SDBNb2RBczloUzdlV2RXSEx5ZDFYSnpLa3BNeGdST0diMnFzTFJHbnB3dXhhU2h2WjFBTC16YkxEN3ZkY2F0dlg1TjZoOThzcV9Xb0Vr?oc=5","date":"2025-02-19","type":"deal","source":"Contract Pharma","summary":"Brexogen, BMI Korea Ink Exosome Therapy Licensing Deal - Contract Pharma","headline":"Brexogen, BMI Korea Ink Exosome Therapy Licensing Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5pMXFFM2lhc2VLcjFtaHc0cGsyeGFsRC1WcUFKazBRZjdRTkpNLTd1ZWJPYkdJZG5Nc0JlSG1xS2lORTRDOUkwRmNTTy00aEhtbHEwRXpMZDdiYUlCNGQ4cTN0dEtianAwUEc0bHJR0gFyQVVfeXFMTXdxLWpPczhaMUtEdnRYR0FUdXpsNnRRbEU2a3ZLMjNqVkJGSGE5UEZaOGRKeVZMVjBibHFPMU01eWxkQWZQNVkxUzN6UV9YVE1oV3FVUjdZRUZlWkZFS1NnMzZzZlE2ekJZVExJaEFreHpB?oc=5","date":"2024-02-02","type":"pipeline","source":"koreabiomed.com","summary":"Meta Fines transfers cancer cachexia drug tech to BMI Korea - koreabiomed.com","headline":"Meta Fines transfers cancer cachexia drug tech to BMI Korea","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}